Leber Hereditary Optic Atrophy
📧 Sign up to get email alerts when something new happens for Leber Hereditary Optic Atrophy.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2023-08-08EMA Application withdrawn: Lumevoq (lenadogene nolparvovec) — GenSight Biologics S.A.
The EMA withdrew the application for Lumevoq (lenadogene nolparvovec) by GenSight Biologics for Leber hereditary optic atrophy.